Medtronic PLC (MDT)
80.24
-0.62
(-0.77%)
USD |
NYSE |
Apr 30, 16:00
80.22
-0.02
(-0.02%)
After-Hours: 20:00
Medtronic Cash from Investing (Quarterly): -707.00M for Jan. 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -707.00M |
| October 31, 2023 | -424.00M |
| July 31, 2023 | -539.00M |
| April 30, 2023 | -475.00M |
| January 31, 2023 | -287.00M |
| October 31, 2022 | -1.146B |
| July 31, 2022 | -1.585B |
| April 30, 2022 | 271.00M |
| January 31, 2022 | -437.00M |
| October 31, 2021 | -709.00M |
| July 31, 2021 | -784.00M |
| April 30, 2021 | 1.919B |
| January 31, 2021 | -2.773B |
| October 31, 2020 | -2.02B |
| July 31, 2020 | 8.00M |
| April 30, 2020 | 365.00M |
| January 31, 2020 | -1.801B |
| October 31, 2019 | -1.216B |
| July 31, 2019 | -551.00M |
| April 30, 2019 | -529.00M |
| January 31, 2019 | -1.009B |
| October 31, 2018 | 121.00M |
| July 31, 2018 | 643.00M |
| April 30, 2018 | 111.00M |
| January 31, 2018 | -378.00M |
| Date | Value |
|---|---|
| October 31, 2017 | 6.042B |
| July 31, 2017 | 83.00M |
| April 30, 2017 | -272.00M |
| January 31, 2017 | -942.00M |
| October 31, 2016 | -73.00M |
| July 31, 2016 | -284.00M |
| April 30, 2016 | 4.573B |
| January 31, 2016 | -254.00M |
| October 31, 2015 | -1.088B |
| July 31, 2015 | -986.00M |
| April 30, 2015 | -15.22B |
| January 31, 2015 | -690.00M |
| October 31, 2014 | -1.147B |
| July 31, 2014 | -6.00M |
| April 30, 2014 | -525.00M |
| January 31, 2014 | -1.217B |
| October 31, 2013 | -1.186B |
| July 31, 2013 | -666.00M |
| April 30, 2013 | -587.00M |
| January 31, 2013 | -1.587B |
| October 31, 2012 | 49.00M |
| July 31, 2012 | -976.00M |
| April 30, 2012 | -481.00M |
| January 31, 2012 | -438.00M |
| October 31, 2011 | -1.146B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.773B
Minimum
Jan 2021
1.919B
Maximum
Apr 2021
-678.47M
Average
-551.00M
Median
Jul 2019
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -824.00M |
| Boston Scientific Corp | -1.053B |
| Stryker Corp | -152.00M |
| Axonics Inc | -37.92M |
| Conmed Corp | -2.035M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.474B |
| Cash from Financing (Quarterly) | -1.50B |
| Free Cash Flow | 4.931B |
| Free Cash Flow Per Share (Quarterly) | 1.598 |
| Free Cash Flow to Equity (Quarterly) | 2.026B |
| Free Cash Flow to Firm (Quarterly) | 2.299B |
| Free Cash Flow Yield | 4.61% |